Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum
Materials Today Bio · 2025-12 · 35 · 102500
DOI: 10.1016/j.mtbio.2025.102500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2025-12. Verfasst von Qonita Kurnia Anjani und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Malaria remains a significant global health burden, particularly in low- and middle-income countries. Artemisinin-based combination therapies (ACTs) are the current gold standard for treating Plasmodium falciparum infections, combining a fast-acting artemisinin derivative with a longer-acting partner drug. However, these oral regimens require multiple doses over several days, which can reduce adherence, compromise parasite clearance, and contribute to the emergence of drug resistance. To overcome these limitations, we developed, for the first time, dissolving microarray patches (MAPs) for the transdermal delivery of amodiaquine and artesunate. Given the different Biopharmaceutics Classification System (BCS) properties of these drugs, amodiaquine (BCS Class III) and artesunate (BCS Class II), Tween® 80 was incorporated to enhance solubility and skin permeability. In vitro release studies demonstrated efficient delivery, with up to 40 % amodiaquine and 90 % artesunate deposited and permeated into the skin. Pharmacokinetic analysis revealed that MAP delivery extended the half-life of artesunate by 8.5-fold (54.05 vs. 6.37 h) and increased its Cmax by 21 % (1796.02 ± 154.50 vs. 1421.93 ± 209.61 ng/mL), while amodiaquine's half-life was prolonged by ∼1.4-fold (57.72 ± 19.16 vs. 40.75 ± 7.44 h). In a Plasmodium berghei-infected murine model, the combined MAP treatment reduced parasitaemia by 99.5 % within seven days, showing comparable efficacy to oral administration. These findings demonstrate that dissolving MAPs offer a minimally invasive, needle-free strategy for ACT delivery, with potential to enhance treatment adherence, reduce gastrointestinal side effects, and combat drug resistance, particularly in resource-limited malaria-endemic settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, UK.
- School of Biomedical Sciences, Ulster University, Mass Spectrometry Centre, Cromore Road, Coleraine, BT52 1SA, UK.
- Department of Pharmaceutical Science, Faculty of Pharmacy, Universitas Airlangga, Campus C UNAIR Mulyorejo, Surabaya, 60115, Indonesia.
- Stem Cell Research and Development Center, Universitas Airlangga, Institute of Tropical Disease Building, Campus C UNAIR Mulyorejo, Surabaya, 60115, Indonesia.
- Basic Science Department, Faculty of Health, Universidad Industrial de Santander, Bucaramanga, 680001, Colombia.
- Department of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Förderung
- Engineering and Physical Sciences Research Council
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Anjani, Q. K., Volpe-Zanuto, F., Miatmoko, A., Moreno-Castellanos, N., Novais, J. T., Gaitán, X. A., Hariawan, B. S., Cahyani, D. M., Octavia, R. T., Mubarok, A. S., Wahyu Setyaningsih, W. A., Johnston, C., Bargieri, D. Y., & Donnelly, R. F. (2025). Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum. Materials Today Bio, 35, 102500. https://doi.org/10.1016/j.mtbio.2025.102500
Vancouver
Anjani QK, Volpe-Zanuto F, Miatmoko A, Moreno-Castellanos N, Novais JT, Gaitán XA, et al. Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum. Materials Today Bio. 2025;35:102500. doi:10.1016/j.mtbio.2025.102500
BibTeX
@article{Anjani2025,
author = {Anjani, Qonita Kurnia and Volpe-Zanuto, Fabiana and Miatmoko, Andang and Moreno-Castellanos, Natalia and Novais, Janaina Tenorio and Gaitán, Xiomara A and Hariawan, Berlian Sarasitha and Cahyani, Devy Maulidya and Octavia, Rifda Tarimi and Mubarok, Ahmad Shahrul and Wahyu Setyaningsih, Wiwit Ananda and Johnston, Callum and Bargieri, Daniel Y and Donnelly, Ryan F},
title = {Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate: A novel strategy against Plasmodium falciparum},
journal = {Materials Today Bio},
year = {2025},
volume = {35},
pages = {102500},
doi = {10.1016/j.mtbio.2025.102500}
}
EUVIMED